GoHealth (GOCO) Cash from Financing Activities (2020 - 2026)

GoHealth has disclosed Cash from Financing Activities across 7 years of filings, most recently posting -$25000.0 for Q1 2026.

• Cash from Financing Activities for Q1 2026 came in at -$25000.0, up 99.22% year-over-year; the trailing twelve-month figure through Mar 2026 was $125.2 million (up 465.06% YoY), and the FY2025 annual result was $122.0 million, up 480.84% from the prior year.
• Cash from Financing Activities came in at -$25000.0 for Q1 2026 at GoHealth, down from $39.9 million in the prior quarter.
• In the past five years, Cash from Financing Activities ranged from a high of $53.9 million in Q2 2025 to a low of -$156.6 million in Q4 2022.
• The 5-year median for Cash from Financing Activities is -$1.4 million (2022), against an average of -$2.7 million.
• Across the five-year window, Cash from Financing Activities tumbled 1036.16% in 2023 and soared 1026.9% in 2024, its largest moves.
• GoHealth's Cash from Financing Activities stood at -$156.6 million in 2022, then surged by 99.31% to -$1.1 million in 2023, then slumped by 541.12% to -$7.0 million in 2024, then surged by 672.66% to $39.9 million in 2025, then sank by 100.06% to -$25000.0 in 2026.
• The last three Cash from Financing Activities figures came in at -$25000.0 (Q1 2026), $39.9 million (Q4 2025), and $31.4 million (Q3 2025), per Business Quant data.